A recent study published by the National Institute of Health and the journal Translational Stroke Research has found that activation of the body’s cannabinoid receptors can reduce the harmful effects of strokes, and can even prevent them entirely.
For the study researchers at the Department of Pathology at Temple University School of Medicine used mouse models to examine the effects of activating the body’s cannabinoid receptors on transient middle cerebral artery occlusion/reperfusion injury (MCAO/R). They found that; “In conclusion, administration of the CB2R agonist/CB1R antagonist combination causes a significant reduction in infarct size in the MCAO/R model.”
According to the study’s lead researcher, these results have important implications for further development of cannabis-based medicines in preventing strokes, as well as treating the symptoms of strokes, given that cannabis naturally activates the body’s endocannabinoid system.
You can click here to find the full study.